Cargando…
Characterization of renal biomarkers for use in clinical trials: effect of preanalytical processing and qualification using samples from subjects with diabetes
BACKGROUND: Identifying the potential for drug-induced kidney injury is essential for the successful research and development of new drugs. Newer and more sensitive preclinical drug-induced kidney injury biomarkers are now qualified for use in rat toxicology studies, but biomarkers for clinical stud...
Autores principales: | Brott, David A, Furlong, Stephen T, Adler, Scott H, Hainer, James W, Arani, Ramin B, Pinches, Mark, Rossing, Peter, Chaturvedi, Nish |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4482374/ https://www.ncbi.nlm.nih.gov/pubmed/26124642 http://dx.doi.org/10.2147/DDDT.S78792 |
Ejemplares similares
-
Characterization of renal biomarkers for use in clinical trials: biomarker evaluation in healthy volunteers
por: Brott, David A, et al.
Publicado: (2014) -
Preanalytical sample handling recommendations for Alzheimer's disease plasma biomarkers
por: Rózga, Małgorzata, et al.
Publicado: (2019) -
Diagnostic biomarkers in tear fluid: from sampling to preanalytical processing
por: Bachhuber, Franziska, et al.
Publicado: (2021) -
Preanalytical stability of plasma biomarkers for Alzheimer's disease pathology
por: Sunde, Anita L., et al.
Publicado: (2023) -
The effect of blood sampling and preanalytical processing on human N-glycome
por: Dědová, Tereza, et al.
Publicado: (2018)